<DOC>
	<DOCNO>NCT03047954</DOCNO>
	<brief_summary>The objective pilot double-blind study evaluate efficacy safety Broncho-Vaxom 1 capsule ( 3.5 mg ) per day 9 month compare placebo evolution disease child suffer Atopic Dermatitis ( AD ) .</brief_summary>
	<brief_title>Broncho-Vaxom ( OM 85 BV ) Children Suffering From Atopic Dermatitis</brief_title>
	<detailed_description>Children outpatient sex , age 6 month 7 year , AD confirm Haniffin-Rajka Williams et al , AD score ( SCORAD ) 25 70 include follow 9 month . Patients randomize receive either Broncho-Vaxom 1 capsule ( 3.5 mg ) per day correspond placebo 9 month . Children general corticotherapy within one month study start , patient immunodeficiency , patient 's affected body surface area le 15 % great 70 % know allergy desonide exclude . Outcome measure comparison two group number AD flare study first month treatment . Secondary outcome measure comparison two group base SCORAD evolution , area eczema , amount corticoid use parents/investigator assessment .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Broncho-Vaxom</mesh_term>
	<criteria>Male female child age 6 month 7 year ( eighth year life ) Children Atopic Dermatitis ( HanifinRajka Williams et al criterion ) affect body surface area ≥15 % ≤ 70 % 25 ≤ SCORAD ≤ 70 Written inform consent obtain parents/legal Guardian ( child applicable ) Children general corticotherapy within one month study start Children immunodeficiency Children malignant disease Children SCORAD &lt; 25 &gt; 70 Children affect body surface area &lt; 15 % &gt; 70 % Children autoimmune disease Children immunosuppressive immunostimulating therapy within 1 month study start Children whose parent Guardians unable comply requirement protocol e.g.completion patient 's diary card Children know allergy previous intolerance know hypersensitivity trial drug corticoid use Participation another clinical trial and/or treatment experimental drug within 3 month study start present trial</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>